Novadel Pharma Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/11 Q3

ended 06/30/11 Q2

ended 03/31/11 Q1

ended 12/31/10 FY 2010 – amended

ended 12/31/10 FY 2010

Prospectuses and Registrations Filter

Securities registration termination

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Moorin Jay, Proquest Investments II Advisors Fund LP, Proquest Investments II LP, Proquest Associates II LLC, Schreiber Alain, ProQuest Investments III, L.P., ProQuest Associates III LLC

Proquest Investments II LP

Bonney Thomas E

Nemeroff Charles

News Filter

Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011

Material Definitive Agreement, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Material Definitive Agreement, Material Disclosure, Financial Statements or Exhibits

Announces Termination of License Agreements for Ondansetron Oral Spray Product

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Confidential treatment order

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC